Intravenous abuse of methylphenidate

Journal of Clinical Psychopharmacology

Volumn 33, Issue 5, 2013, Pages 720-721

  Imbert, Bruce ^a   Cohen, Julien ^a   Simon, Nicolas ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; CLONAZEPAM; FLUNITRAZEPAM; METHYLPHENIDATE; ZOLPIDEM;

ABDOMINAL PAIN; ADULT; ANXIETY; CASE REPORT; DELUSION; DYSPHORIA; EUPHORIA; HEALING; HUMAN; INTELLECT; INTRAVENOUS DRUG ABUSE; LETTER; LOW BACK PAIN; MALE; MENTAL CONCENTRATION; NAUSEA; PARANOIA; PRIORITY JOURNAL; SELF MEDICATION; SHIVERING; SLEEP DISORDER; SPEECH; SWEATING; VERBOACOUSTIC DELUSION; VOMITING; WEIGHT REDUCTION; WITHDRAWAL SYNDROME;

ADULT; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG USERS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; METHYLPHENIDATE; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84883787140     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31829839a4     Document Type: Letter

References (13)

1. Morton WA, Stockton GG. Methylphenidate abuse and psychiatric side effects. Prim Care Companion J Clin Psychiatry. 2000;2(5):159-164
2. Leonard BE, McCartan D, White J, et al. Methylphenidate: A review of its neuropharmacological, neuropsychological and adverse clinical effects. Hum Psychopharmacol. 2004;19(3): 151-180
3. Biederman J, Monuteaux MC, Spencer T, et al. Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: A naturalistic controlled 10-year follow-up study. Am J Psychiatry. 2008;165(5): 597-603
4. Frauger E, Spadari M, Djezzar S. Study on intravenous use of methylphenidate and patterns on its abuse and diversion in two French administrative areas. Le Courrier des Addictions. 2011;13(4): 15-20
5. Farquhar S, Fawcett P, Fountain J. Illicit intravenous use of methylphenidate (Ritalin) tablets: A review of four cases. Aust Emerg Nurs. 2002;5(2):25-29
6. Lundquest D, Young W, Edland J. Maternal death associated with intravenous methylphenidate (Ritalin) and pentazocine (talwin) abuse. J Forensic Sci. 1987;32(3):798-801
7. Parran T, Jasinski D. Intravenous methylpenidate abuse. Prototype for prescription drug abuse. Arch Intern Med. 1991;151(4):781-783
8. Trugman J. Cerebral arteritis and oral methylphenidate. Lancet. 1988;1(8585): 584-585
9. Cahill D, Knipp H, Mosser J. Intracranial haemorrhage with amphetamine abuse. Neurology. 1981;31:1058-1059
10. Levine B, Caplan Y, Kauffman G. Fatality resulting from methylphenidate overdose. J Anal Toxicol. 1986;10(5):209-210
11. Del Giudice P, Vandenbos F, Boissy C, et al. Cutaneous complications of direct intra-Arterial injections in drug addicts. Acta Derm Venereol. 2005;85(5):451-452
12. Grau D, Vidal N, Faucherre V, et al. Infectious adverse events related to misuse of high-dose buprenorphine: A retrospective study of 42 cases. Rev Med Int. 2010;31(3):188-193
13. Spencer TJ, Biederman J, Ciccone PE, et al. PET study examining pharmaco-kinetics, detection and likeability, and dopamine transporter receptor occupancy of short-And long-Acting oral methylphenidate. Am J Psychiatry. 2006;163(3):387-395